Retatrutide, Amycretin, Survodutide, VK2735, and MariTide are among the most watched pipeline assets heading into 2026 because each represents a different answer to the same commercial question: what comes after Ozempic, Wegovy, Mounjaro, and Zepbound
After asking whether Medicare should cover the cost of GLP-1s when prescribed for weight loss for people who are overweight, the poll presented two different arguments for and against this proposal: Argument against: Some people say that if Medicare covers the cost of these drugs, it could increase premiums paid by people with Medicare and place financial pressure on the Medicare program and the federal budget
In addition to that, semaglutide headaches can be lessened or avoided by eating regular small meals that are low in sugars, and staying hydrated throughout the day
Nothing else is even close. The very same class of medications, GLP-1 agonists, that he promoted comes from government funded science that started in the 1980s with curious scientists testing a variety of venoms on guinea pig pancreases
Preventive cardiology is not separate from brain health
The bigger risk to absorption is not which site you pick
